美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.46

+0.39151.56%

成交量：561

成交額：1.43萬

市值：585.67萬

市盈率：- -

高：25.46

開：25.42

低：25.42

收：25.07

52周最高：27.94

52周最低：22.63

股本：23.00萬

流通股本：23.00萬

量比：1.01

換手率：0.24%

股息：0.41

股息率：1.62%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

諾和諾德（NVO）長效生長激素Sogroya®獲歐盟CHMP積極意見擬用於兒科特發性矮小症

因與禮來達成交易，GenScript Biotech 股價延續漲勢，逼近5年高點

諾和諾德(NVO)股票9月17日盤中上漲3.02%：投資者必看的核心信息

TradingKey中文

諾和諾德（NVO）聯手Orbis加碼AI新藥研發部署高達14億美元合作協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/THNR"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":25.4637,"timestamp":1789675200000,"preClose":25.0722,"halted":0,"volume":561,"delay":0,"changeRate":0.0156149041567952,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"盤前交易","change":0.3915,"latestTime":"09-18 08:44:51 EDT","open":25.42,"high":25.4637,"low":25.42,"amount":14272,"amplitude":0.001743,"askPrice":40.74,"askSize":200,"bidPrice":10.19,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":25.4637,"sharesOutstanding":170000,"nav":25.11,"aum":5775300,"dividendRate":0.0162,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.42,"preClose":25.4637,"latestTime":"16:10 EDT","volume":6,"amount":152.7148,"timestamp":1789675804475,"change":-0.0437,"changeRate":-0.001716,"amplitude":0},"volumeRatio":1.0115400491695012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":230000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0115400491695012,"shares":230000,"dividePrice":0.4125,"high":25.4637,"amplitude":0.001743,"preClose":25.0722,"low":25.42,"week52Low":22.6289,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":25.4637,"eps":0,"divideRate":0.0162,"volume":561,"delay":0,"ttmEps":0,"open":25.42,"prevYearClose":25.22,"prevWeekClose":25.59,"prevMonthClose":26.6886,"prevQuarterClose":25.6909,"fiveDayClose":25.7032,"twentyDayClose":27.5304,"sixtyDayClose":24.6746},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668940474","title":"諾和諾德（NVO）長效生長激素Sogroya®獲歐盟CHMP積極意見 擬用於兒科特發性矮小症","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940474","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940474?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:58","pubTimestamp":1789729104,"startTime":"0","endTime":"0","summary":"特发性矮小症影响全球高达3%的儿童。REAL8III期临床试验数据显示，在第52周时，每周注射一次Sogroya在改善患儿平均年化身高增长速度方面，疗效不劣于每日注射一次的传统生长激素疗法。据介绍，若最终获批，Sogroya将成为欧盟首个且唯一用于治疗特发性矮小症的生长激素疗法。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306223","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVOX","NVOH","BK4585","THNR","LU1093756325.SGD","NVOC","BK4532","BK4599","NVO","IE00BKVL7J92.USD","PPH","OZEM","BK4007","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919568","title":"因與禮來達成交易，GenScript Biotech 股價延續漲勢，逼近5年高點","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919568","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668919568?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 10:10","pubTimestamp":1789697442,"startTime":"0","endTime":"0","summary":"BUZZ-因与礼来达成交易，GenScript Biotech 股价延续涨势，逼近5年高点9月18日-** 基因脚本生物科技公司（1548.HK）股价大涨8.2%，至40.28港元，创下自2021年12月以来的最高水平** 受与礼来公司（Eli Lilly and Company）达成合作消息提振，该股延续前一交易日的涨势LLY.N** 该股成为恒生生物科技指数.HSBIO中涨幅第三大的个股，该指","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4T45A05A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018857.SGD","SG9999013999.USD","IE00B4JS1V06.HKD","LU0316494557.USD","HRTS","IE00BFTCPJ56.SGD","IE00B775H168.HKD","LU0882574139.USD","LU1093756325.SGD","LU2602419157.SGD","LU0006306889.USD","LU0203201768.USD","LU0820562030.AUD","MHIP","LU2168564149.EUR","MEDI","LU2462591350.SGD","BK1583","LU0289739699.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","LU1712237335.SGD","LU2264538146.SGD","LU1127390331.HKD","LU0786609619.USD","LU0133085943.USD","LU2111349929.HKD","LU1917777945.USD","LU0203202063.USD","ELIS","LU0823416689.USD","LU1868837300.USD","LU2468319806.SGD","SG9999001176.SGD","LU2237438978.USD","LU0256863811.USD","LU2552382058.USD","RXL","LU2456880835.USD","SG9999015945.SGD","SGXZ31699556.SGD","LU1974910355.USD","IE00BJT1NW94.SGD","HK0000306701.USD","LU0198837287.USD","AGNG","GB00BDT5M118.USD","LU2750360641.GBP","LU2361045086.USD","SGXZ81514606.USD","LU2168564495.EUR","LU2237443978.SGD","SG9999014914.USD","LU0471298694.HKD","LU2491050154.USD","LU0096364046.USD","LU2213496289.HKD","BK4534","IE00BK4W5M84.HKD","IHE","LU2237443382.USD","LU1868836591.USD","BK4581","LU0417517546.SGD","LU2552382215.SGD","BK4007","LU0820561818.USD","LU1232071149.USD","LU0114720955.EUR","LU0225283273.USD","LU2361044865.SGD","LU1551013425.SGD","LU1983299246.USD","LU0158827781.USD","IE00BWXC8680.SGD","BK4585","LU0882574055.USD","LU2023251221.USD","LU2087625088.SGD","LU2089984988.USD","IE0005OL40V9.USD","LU1145028129.USD","LU2236285917.USD","BK1576","LU0238689110.USD","HK0000306685.HKD","LU0320765992.SGD","LU2237443549.SGD","LU2491050071.SGD","SG9999014906.USD","LU1720051108.HKD","LU1979441026.SGD","ELIL","LU1551013342.USD","PPH","LU0097036916.USD","LU0689472784.USD","LU2112291526.USD","LU2168563687.JPY","IE00BKDWB100.SGD","LU0683600562.USD","LU1069344957.HKD","LU1814569148.SGD","BK4533","LU0672654240.SGD","LU0109391861.USD","LU2106854487.HKD","HK0000320264.USD","BK4599","LU2361044949.HKD","SG9999017495.SGD","TRUH","LU1035775433.USD","LU0158827948.USD","LU1629891620.HKD","LU2023250330.USD","LU0079474960.USD","TMED","LU0061475181.USD","LU0456855351.SGD","LU2271345857.HKD","IE00BJJMRX11.SGD","LU0234572021.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE0004445015.USD","SG9999015986.USD","HK0000320223.HKD","CANC","WDNA","LU0964807845.USD","BK4516","IE00BK4W5L77.USD","LU0820561909.HKD","IE0001KFT4U8.USD","LU2028103732.USD","LU2896262040.SGD","SGXZ99366536.SGD","OZEM","LU1691799644.USD","SG9999014898.SGD","LU0823434740.USD","LU2552382132.HKD","BK4588","LU0354030438.USD","LU0471298777.SGD","LU2265009873.SGD","PJP","LU0106261372.USD","LU0345770308.USD","FTXH","SG9999015952.SGD","LU1267930730.SGD","LU1989771016.USD","SG9999014880.SGD","FHLC","LU2324357040.USD","LU2461242641.AUD","LU2471134879.HKD","LU2746668461.USD","IE00BFSS8Q28.SGD","LU2750360997.AUD","LU0174119429.USD","LU0320765059.SGD","LU2746668974.SGD","VHT","LU0353189680.USD","LU1291159041.SGD","LU2168564222.USD","LU2023250504.SGD","LU0323591593.USD","LU2211815571.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B1BXHZ80.USD","LU2756315318.SGD","LU2168564065.EUR","LU2237443622.USD","LU1323610961.USD","LU1868837136.USD","IE00BKPKM429.USD","LLYX","LU2756315664.SGD","LU0094547139.USD","THNR","LU2471134952.CNY","LU1093756168.USD","LU2491049909.HKD","MEDX","LU1623119135.USD","LU1868836914.USD","LU2471134796.USD","SG9999001176.USD","SGXZ57979304.SGD","XLV","LU2237443465.HKD","IE0002141913.USD","LU1868836757.USD","LU2237443895.HKD","CURE","LU1548497426.USD","LLY","LU1280957306.USD","GDOC","LU0466842654.USD","IE00B2B36J28.USD","LU2089283258.USD","LU1720051017.SGD","LU2471134523.USD","LU1064131342.USD","LLII","IE00B7KXQ091.USD","LU0353189763.USD","JDOC","IE0004445239.USD","ILDR","LU0432979614.USD","LU1804176565.USD","LU2360106947.USD","LU2417539215.USD","IE00BN29S564.USD","BK1141","LU0122379950.USD","LU1988902786.USD","LU1023059063.AUD","LU0266013472.USD","LU1366192091.USD","LU0787776722.HKD","SGXZ51526630.SGD","LU0345770993.USD","IE00BJLML261.HKD","LU0109394709.USD","LU2462157665.USD","LU0889565916.HKD","LU2063271972.USD","LU1061106388.HKD","LU2357305700.SGD","IXJ","LU0708995401.HKD","IYH","LLYZ","LU0354030511.USD","LU2108987350.USD","SG9999018865.SGD","LU0210536198.USD","LU0385154629.USD","IE00BJJMRY28.SGD","LU0058720904.USD","01548","LU0256863902.USD","LU1057294990.SGD","LU0943347566.SGD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999538","title":"諾和諾德(NVO)股票9月17日盤中上漲3.02%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999538","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999538?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 00:16","pubTimestamp":1789661773,"startTime":"0","endTime":"0","summary":"• 诺和诺德与 Orbis Medicine 达成合作，开展 AI 驱动的口服心血管与代谢药物研发。\n• 欧洲监管机构对用于治疗甲型血友病的 Frehemgo 发布了积极的上市推荐意见。\n• 该公司公布的全年营收为 467.0 亿美元，净利润为 154.8 亿美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262173640-market-movers-nvo-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","BK4585","NVOX","OZEM","NVOH","BK4599","LU1093756325.SGD","NVO","THNR","LU0154236417.USD","BK4007","NVOC","PPH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964155","title":"諾和諾德（NVO）聯手Orbis加碼AI新藥研發 部署高達14億美元合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964155","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668964155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 19:54","pubTimestamp":1789646089,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹麦生物技术初创公司Orbis Medicine宣布，已与抗糖尿病及减肥药巨头诺和诺德 达成一项总价值最高可达14亿美元的药物研发合作协议，旨在共同开发针对心血管及代谢类疾病的新一代疗法。作为合作的一环，诺和诺德将对Orbis进行战略投资。Orbis有权获得来自诺和诺德最高达14亿美元的资金支持，其中包括预付款、后续潜在的研发与商业化里程碑付款等。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306171","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4585","OZEM","BK4588","BK4599","LU1093756168.USD","NVOH","LU1093756325.SGD","BK4007","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","NVOC","NVOX","PPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/THNR\",params:#limit:6,delay:false,,,undefined,":[]}}